Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
73.73
-1.11 (-1.48%)
Nov 20, 2024, 4:00 PM EST - Market closed
Henry Schein Revenue
Henry Schein had revenue of $3.17B in the quarter ending September 28, 2024, with 0.38% growth. This brings the company's revenue in the last twelve months to $12.50B, down -1.53% year-over-year. In the year 2023, Henry Schein had annual revenue of $12.34B, down -2.44%.
Revenue (ttm)
$12.50B
Revenue Growth
-1.53%
P/S Ratio
0.76
Revenue / Employee
$499,960
Employees
25,000
Market Cap
9.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | 9.99B | 568.20M | 6.03% |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 26, 2015 | Pro | Pro | Pro |
| Dec 27, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Charles River Laboratories International | 4.06B |
| Teleflex | 3.03B |
| Exact Sciences | 2.69B |
| Bio-Rad Laboratories | 2.58B |
| Exelixis | 2.08B |
| Medpace Holdings | 2.07B |
| Qiagen | 1.97B |
| Penumbra | 1.16B |
HSIC News
- 3 hours ago - Henry Schein to Participate in Investor Conferences in December - Business Wire
- 1 day ago - Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products - Business Wire
- 2 days ago - Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say - Reuters
- 2 days ago - Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits - CNBC
- 15 days ago - Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Henry Schein beats quarterly profit estimates on lower costs - Reuters
- 16 days ago - Henry Schein Reports Third Quarter 2024 Financial Results and Increases 2024 Financial Guidance - Business Wire
- 27 days ago - Federman & Sherwood Investigates Henry Schein, Inc. for Data Breach - Business Wire